loader2
Partner With Us NRI

Trident Lifeline Ltd share Price Today

Company details

170.00
180.00
128.25
239.70
6M Return -9.95%
1Y Return 24.30%
Mkt Cap.(Cr) 202.96
Volume 4,800
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 4,800

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Trident Lifeline Ltd shares SWOT Analysis

Strengths (3)

  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • FII / FPI or Institutions increasing their shareholding

Weakness (7)

  • Promoters increased pledged shares QoQ
  • Promoter holding decreased by more than -2% QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Opportunity (0)

Data not found

Threats (2)

  • Promoter decreasing their shareholding
  • Big Deal (Insider and SAST) sells last month greater than 1% of total shares

Resistance and support

R1 180.8
R2 185.4
R3 190.8
Pivot

175.42

S1 170.8
S2 165.4
S3 160.8
EMA SMA
169.4
168.5
171.5
169.9
169.8
165.6
173.7
183.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
RINKAL MAYURBHAI GAJERA Bulk Sell 2024-05-16 178.75 63000 BSE
SANDHYA SINGH GAHLOUT Bulk Purchase 2024-03-19 157.55 80400 BSE
PRSSB SERVICES LIMITED Bulk Sell 2024-03-19 157.55 80400 BSE
Name Category Shares
Hardik Jigishkumar DesaI PROMOTER 21.85%
Rinkal Mayurbhai Gajera PROMOTER 8.04%
Anjanaben Jigishkumar Desai PROMOTER 7.03%
Rupaben Chetanbhai Jariwala PROMOTER 5.84%
Tarang Nathabhai Gajera PROMOTER 5.84%
Mayurkumar Mansukhbhai Gajera PROMOTER 5.63%
Mohak Gajera PROMOTER 4.13%
Amit Bhupendra Halvawala PROMOTER 1.19%
HARDIK JIGISHKUMAR DESAI, MANIYA HARDIK DESAI, ANJANABEN JIGISHKUMAR DESAI ON BEHALF OF HARDIK DESAI PROMOTER 4.9%
Trident Texofab Limited PROMOTER 1.98%
Niyati Roshan Thakkar PROMOTER 1.05%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Trident Lifeline Ltd Stocks COMPARISON

Financials( in Cr) Trident Lifeline Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 176.50 1,516.00 1,564.75 4,588.60 1,109.55
% Change -4.08 0.34 1.31 -0.11 1.75
Mcap Cr 202.96 363,739.19 126,332.75 121,813.11 111,646.69
Revenue TTM Cr 31.69 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 6.02 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 31.93 36.34 29.68 76.10 28.94
1 Year Return 24.30 53.43 59.42 31.57 114.34
ROCE 22.84 16.79 14.76 19.30 16.25
ROE 22.44 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 45.64 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 33,119.99 -408.46
LAST 3M 113,155.52 -36,230.77
LAST 6M 183,603.09 -15,050.11
LAST 12M 290,144.87 98,834.05

Trident Lifeline Ltd Information

Stock PE (TTM)
31.93
Promoter Holding
67.48%
Book Value
45.1416
ROCE
22.84%
ROE
22.44%
Description
  • Trident Lifeline Limited was originally incorporated as Private Limited Company under the name "Trident Lifeline Private Limited" on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders` Resolution on June 02, 2022 and name of Company was changed to "Trident Lifeline Limited" on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It operate in India as well as African, Latin American and East Indian Countries. Presently, it has presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venezuela. Presently, Company operates with one contract manufacturer, who maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under their own brands. Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. The Company typically work on contract manufacturing basis or at times purchase order basis, depending upon customer`s requirement, with manufacturer of pharma products. The Company deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. The product portfolio comprises of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflammatory drug (NSAIDS). The Company had Certified its Quality Management System Under the Certificate ISO 9001: 2015 in FY 2021. Besides, product portfolio consists of 832 products, which operated under different brand names across the globe as on May 31, 2022. As on May 31, 2022, the Company has 267 products registered in total 8 countries, of which total 565 products are under process of registration in 11 countries.

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1200
BSE Code : 543616
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : M
ISIN : INE0MKA01014

FAQ’s on Trident Lifeline Ltd Shares

You can buy Trident Lifeline Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Trident Lifeline Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 04:01 PM the closing price of Trident Lifeline Ltd was Rs.176.50.

The latest PE ratio of Trident Lifeline Ltd as of Jun 14, 2024 04:01 PM is 31.93

The latest PB ratio of Trident Lifeline Ltd as of Jun 14, 2024 04:01 PM is 0.26

The 52-week high of Trident Lifeline Ltd share price is Rs. 239.70 while the 52-week low is Rs. 128.25

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 04:01 PM, the market cap of Trident Lifeline Ltd stood at Rs. 202.96.

Download App

Download Our App

Play Store App Store
market app